PSCHETF / FundInvesco S&P SmallCap Health Care ETF
Verdicts genuinely change. Free email alert the moment PSCH's does — no target price to set, unlike "Alert" above.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
Invesco S&P SmallCap Health Care ETF · Invesco Exchange-Traded Fund Trust II
81 holdings · as of 2026-05-31 (4.9 months ago) The fund may have traded since. SEC Form N-PORT is filed quarterly and lags the period it covers, so these are the most recent holdings on file, not the fund’s holdings today.
This fund holds short positions, so exposure is counted gross — long and short both count as exposure rather than netting off, and the weights below therefore sum to 130% of net assets rather than 100%. Shares of the portfolio are shown as shares of that gross exposure.
NON-COMPLIANT At least 40.63% of portfolio weight is in non-compliant holdings — already over the 5% threshold, so the verdict is settled whatever the unmatched 45% turns out to be. Matching more holdings can only raise this share, never lower it.
81 holdings, 62 matched (66% of weight). Portfolio as of 2026-05-31, filed 2026-07-28. Source: SEC Form N-PORT.
3.90% of this portfolio’s income is non-permissible — weighted across holdings, computed over 55% of portfolio weight (53 of 81 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
Portfolio shares are withheld: coverage is below the floor needed to state one. The holdings themselves are below, because the names are evidence you can check.
All holdings (81)
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| Invesco Private Prime Fund | UNSCREENED | 21.48% | no in-house ratios for this holding |
| Invesco Private Government Fund | UNSCREENED | 8.27% | no in-house ratios for this holding |
| MOH Molina Healthcare, Inc. | NON_COMPLIANT | 4.77% | AAOIFI36.0% Usmani24.7% Dow Jones Islamic29.7% S&P Shariah24.7% MSCI Islamic23.6% MSCI Islamic M-Series24.7% FTSE Shariah23.6% |
| BTSG BrightSpring Health Services, Inc. | COMPLIANT | 4.35% | AAOIFI19.9% Usmani39.9% Dow Jones Islamic37.1% S&P Shariah45.1% MSCI Islamic39.6% MSCI Islamic M-Series45.1% FTSE Shariah36.6% |
| KRYS Krystal Biotech, Inc. | NON_COMPLIANT | 4.25% | AAOIFI0.1% Usmani0.6% Dow Jones Islamic0.1% S&P Shariah0.2% MSCI Islamic0.6% MSCI Islamic M-Series0.2% FTSE Shariah0.0% |
| ALKS Alkermes PLC | COMPLIANT | 3.71% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| CORT Corcept Therapeutics Inc. | COMPLIANT | 3.47% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| GKOS Glaukos Corp. | COMPLIANT | 3.17% | AAOIFI0.9% Usmani17.3% Dow Jones Islamic1.4% S&P Shariah1.5% MSCI Islamic10.0% MSCI Islamic M-Series1.5% FTSE Shariah6.2% |
| PTCT PTC Therapeutics, Inc. | NON_COMPLIANT | 3.16% | AAOIFI11.9% Usmani21.4% Dow Jones Islamic16.9% S&P Shariah20.0% MSCI Islamic21.2% MSCI Islamic M-Series20.0% FTSE Shariah18.2% |
| PTGX Protagonist Therapeutics, Inc. | NON_COMPLIANT | 3.12% | AAOIFI0.1% Usmani1.0% Dow Jones Islamic0.2% S&P Shariah0.3% MSCI Islamic1.0% MSCI Islamic M-Series0.3% FTSE Shariah0.0% |
| TFX Teleflex Inc. | NON_COMPLIANT | 3.03% | AAOIFI50.9% Usmani44.0% Dow Jones Islamic46.9% S&P Shariah39.1% MSCI Islamic44.0% MSCI Islamic M-Series39.1% FTSE Shariah41.4% |
| TGTX TG Therapeutics, Inc. | COMPLIANT | 2.75% | AAOIFI8.8% Usmani46.0% Dow Jones Islamic13.7% S&P Shariah17.0% MSCI Islamic46.0% MSCI Islamic M-Series17.0% FTSE Shariah45.5% |
| LGND Ligand Pharmaceuticals Inc. | COMPLIANT | 2.43% | AAOIFI19.7% Usmani51.8% Dow Jones Islamic34.1% S&P Shariah42.6% MSCI Islamic51.8% MSCI Islamic M-Series42.6% FTSE Shariah51.5% |
| INDV Indivior Pharmaceuticals, Inc. | COMPLIANT | 2.40% | AAOIFI12.3% Usmani41.3% Dow Jones Islamic17.8% S&P Shariah18.8% MSCI Islamic41.3% MSCI Islamic M-Series18.8% FTSE Shariah39.5% |
| RadNet, Inc. | UNSCREENED | 2.06% | no in-house ratios for this holding |
| MMSI Merit Medical Systems, Inc. | COMPLIANT | 1.99% | AAOIFI15.3% Usmani28.6% Dow Jones Islamic15.9% S&P Shariah16.6% MSCI Islamic28.6% MSCI Islamic M-Series16.6% FTSE Shariah25.7% |
| VCYT Veracyte, Inc. | COMPLIANT | 1.95% | AAOIFI1.1% Usmani2.7% Dow Jones Islamic1.4% S&P Shariah1.6% MSCI Islamic2.7% MSCI Islamic M-Series1.6% FTSE Shariah0.0% |
| Catalyst Pharmaceuticals, Inc. | UNSCREENED | 1.92% | no in-house ratios for this holding |
| OGN Organon & Co. | NON_COMPLIANT | 1.85% | AAOIFI236.4% Usmani64.9% Dow Jones Islamic282.4% S&P Shariah250.1% MSCI Islamic64.9% MSCI Islamic M-Series250.1% FTSE Shariah64.9% |
| ICUI ICU Medical, Inc. | NON_COMPLIANT | 1.78% | AAOIFI32.0% Usmani32.4% Dow Jones Islamic35.8% S&P Shariah38.7% MSCI Islamic32.3% MSCI Islamic M-Series38.7% FTSE Shariah31.0% |
| ITGR Integer Holdings Corp. | NON_COMPLIANT | 1.67% | AAOIFI30.5% Usmani39.9% Dow Jones Islamic35.6% S&P Shariah36.3% MSCI Islamic38.4% MSCI Islamic M-Series36.3% FTSE Shariah36.2% |
| Concentra Group Holdings Parent, Inc. | UNSCREENED | 1.58% | no in-house ratios for this holding |
| ACAD Acadia Pharmaceuticals Inc. | COMPLIANT | 1.45% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| SUPN Supernus Pharmaceuticals, Inc. | COMPLIANT | 1.41% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| PRVA Privia Health Group, Inc. | NON_COMPLIANT | 1.33% | AAOIFI0.3% Usmani0.6% Dow Jones Islamic0.3% S&P Shariah0.3% MSCI Islamic0.6% MSCI Islamic M-Series0.3% FTSE Shariah0.0% |
| ALHC Alignment Healthcare, Inc. | COMPLIANT | 1.31% | AAOIFI11.6% Usmani25.3% Dow Jones Islamic10.0% S&P Shariah12.5% MSCI Islamic25.3% MSCI Islamic M-Series12.5% FTSE Shariah25.3% |
| TMDX TransMedics Group, Inc. | NON_COMPLIANT | 1.22% | AAOIFI0.8% Usmani25.5% Dow Jones Islamic0.7% S&P Shariah0.8% MSCI Islamic1.8% MSCI Islamic M-Series0.8% FTSE Shariah1.4% |
| NHC National HealthCare Corp. | COMPLIANT | 1.22% | AAOIFI0.9% Usmani2.0% Dow Jones Islamic1.5% S&P Shariah1.7% MSCI Islamic2.0% MSCI Islamic M-Series1.7% FTSE Shariah0.0% |
| WAY Waystar Holding Corp. | NON_COMPLIANT | 1.22% | AAOIFI36.9% Usmani25.2% Dow Jones Islamic26.1% S&P Shariah— MSCI Islamic25.2% MSCI Islamic M-Series— FTSE Shariah25.0% |
| Prestige Consumer Healthcare Inc. | UNSCREENED | 1.20% | no in-house ratios for this holding |
| Amneal Pharmaceuticals, Inc. | UNSCREENED | 1.19% | no in-house ratios for this holding |
| RCUS Arcus Biosciences, Inc. | COMPLIANT | 1.15% | AAOIFI4.0% Usmani12.3% Dow Jones Islamic5.6% S&P Shariah6.2% MSCI Islamic12.3% MSCI Islamic M-Series6.2% FTSE Shariah10.9% |
| ACHC Acadia Healthcare Co., Inc. | NON_COMPLIANT | 1.14% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| PGNY Progyny, Inc. | COMPLIANT | 1.09% | AAOIFI1.4% Usmani3.8% Dow Jones Islamic1.5% S&P Shariah1.2% MSCI Islamic3.8% MSCI Islamic M-Series1.2% FTSE Shariah0.0% |
| OMCL Omnicell, Inc. | COMPLIANT | 1.06% | AAOIFI12.8% Usmani10.0% Dow Jones Islamic11.5% S&P Shariah11.9% MSCI Islamic10.0% MSCI Islamic M-Series11.9% FTSE Shariah8.4% |
| LMAT LeMaitre Vascular, Inc. | COMPLIANT | 1.05% | AAOIFI1.2% Usmani3.3% Dow Jones Islamic1.0% S&P Shariah1.1% MSCI Islamic3.3% MSCI Islamic M-Series1.1% FTSE Shariah0.0% |
| NEOG Neogen Corp. | NON_COMPLIANT | 1.04% | AAOIFI31.3% Usmani24.3% Dow Jones Islamic40.7% S&P Shariah32.4% MSCI Islamic24.3% MSCI Islamic M-Series32.4% FTSE Shariah23.7% |
| CRVL CorVel Corp. | COMPLIANT | 1.03% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| ADMA ADMA Biologics, Inc. | COMPLIANT | 1.01% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahpass |
| Sarepta Therapeutics, Inc. | UNSCREENED | 1.00% | no in-house ratios for this holding |
| Select Medical Holdings Corp. | UNSCREENED | 0.97% | no in-house ratios for this holding |
| MD Pediatrix Medical Group, Inc. | NON_COMPLIANT | 0.97% | AAOIFI28.7% Usmani29.1% Dow Jones Islamic39.4% S&P Shariah47.3% MSCI Islamic29.1% MSCI Islamic M-Series47.3% FTSE Shariah27.4% |
| LFST LifeStance Health Group, Inc. | COMPLIANT | 0.93% | AAOIFI9.7% Usmani21.7% Dow Jones Islamic17.3% S&P Shariah18.0% MSCI Islamic21.7% MSCI Islamic M-Series18.0% FTSE Shariah12.5% |
| UFPT UFP Technologies, Inc. | COMPLIANT | 0.90% | AAOIFI6.1% Usmani20.0% Dow Jones Islamic7.3% S&P Shariah7.6% MSCI Islamic20.0% MSCI Islamic M-Series7.6% FTSE Shariah17.2% |
| VCEL Vericel Corp. | COMPLIANT | 0.90% | AAOIFI4.0% Usmani18.5% Dow Jones Islamic4.4% S&P Shariah4.4% MSCI Islamic18.4% MSCI Islamic M-Series4.4% FTSE Shariah0.0% |
| ADUS Addus HomeCare Corp. | COMPLIANT | 0.89% | AAOIFI4.9% Usmani7.5% Dow Jones Islamic5.3% S&P Shariah5.7% MSCI Islamic7.5% MSCI Islamic M-Series5.7% FTSE Shariah4.2% |
| Astrana Health, Inc. | UNSCREENED | 0.87% | no in-house ratios for this holding |
| INVA Innoviva, Inc. | NON_COMPLIANT | 0.81% | AAOIFI17.5% Usmani15.8% Dow Jones Islamic19.8% S&P Shariah21.9% MSCI Islamic15.8% MSCI Islamic M-Series21.9% FTSE Shariah15.2% |
| PRGO Perrigo Co. PLC | NON_COMPLIANT | 0.81% | AAOIFI167.1% Usmani45.6% Dow Jones Islamic136.7% S&P Shariah120.3% MSCI Islamic45.5% MSCI Islamic M-Series120.3% FTSE Shariah43.3% |
| STAA STAAR Surgical Co. | COMPLIANT | 0.79% | AAOIFI3.1% Usmani7.6% Dow Jones Islamic3.1% S&P Shariah2.6% MSCI Islamic7.6% MSCI Islamic M-Series2.6% FTSE Shariah0.0% |
| FTRE Fortrea Holdings Inc. | NON_COMPLIANT | 0.76% | AAOIFI66.4% Usmani41.2% Dow Jones Islamic92.8% S&P Shariah65.5% MSCI Islamic41.2% MSCI Islamic M-Series65.5% FTSE Shariah38.8% |
| ANIP ANI Pharmaceuticals, Inc. | NON_COMPLIANT | 0.75% | AAOIFI18.1% Usmani20.2% Dow Jones Islamic16.7% S&P Shariah17.8% MSCI Islamic20.2% MSCI Islamic M-Series17.8% FTSE Shariah20.2% |
| NEO NeoGenomics, Inc. | COMPLIANT | 0.73% | AAOIFI20.0% Usmani33.2% Dow Jones Islamic30.1% S&P Shariah27.0% MSCI Islamic32.7% MSCI Islamic M-Series27.0% FTSE Shariah27.7% |
| ENOV Enovis Corp. | NON_COMPLIANT | 0.69% | AAOIFI122.4% Usmani34.8% Dow Jones Islamic71.7% S&P Shariah60.3% MSCI Islamic34.8% MSCI Islamic M-Series60.3% FTSE Shariah34.1% |
| Harmony Biosciences Holdings, Inc. | UNSCREENED | 0.67% | no in-house ratios for this holding |
| TNDM Tandem Diabetes Care, Inc. | NON_COMPLIANT | 0.62% | AAOIFI53.4% Usmani64.0% Dow Jones Islamic49.0% S&P Shariah43.9% MSCI Islamic64.0% MSCI Islamic M-Series43.9% FTSE Shariah52.2% |
| Avanos Medical, Inc. | UNSCREENED | 0.61% | no in-house ratios for this holding |
| AMN Healthcare Services, Inc. | UNSCREENED | 0.59% | no in-house ratios for this holding |
| CNMD CONMED Corp. | NON_COMPLIANT | 0.59% | AAOIFI61.3% Usmani36.3% Dow Jones Islamic52.9% S&P Shariah43.7% MSCI Islamic36.3% MSCI Islamic M-Series43.7% FTSE Shariah36.3% |
| AHCO AdaptHealth Corp. | NON_COMPLIANT | 0.58% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| VIR Vir Biotechnology, Inc. | NON_COMPLIANT | 0.57% | AAOIFI6.1% Usmani7.7% Dow Jones Islamic8.6% S&P Shariah8.1% MSCI Islamic7.7% MSCI Islamic M-Series8.1% FTSE Shariah0.0% |
| INSP Inspire Medical Systems, Inc. | COMPLIANT | 0.57% | AAOIFI1.6% Usmani3.1% Dow Jones Islamic0.8% S&P Shariah0.7% MSCI Islamic3.1% MSCI Islamic M-Series0.7% FTSE Shariah0.0% |
| IART Integra LifeSciences Holdings Corp. | NON_COMPLIANT | 0.57% | AAOIFI68.0% Usmani24.8% Dow Jones Islamic70.3% S&P Shariah50.6% MSCI Islamic24.8% MSCI Islamic M-Series50.6% FTSE Shariah19.8% |
| COLL Collegium Pharmaceutical, Inc. | NON_COMPLIANT | 0.57% | AAOIFI31.8% Usmani11.4% Dow Jones Islamic21.9% S&P Shariah22.5% MSCI Islamic11.4% MSCI Islamic M-Series22.5% FTSE Shariah11.2% |
| U.S. Physical Therapy, Inc. | UNSCREENED | 0.52% | no in-house ratios for this holding |
| BLFS BioLife Solutions, Inc. | COMPLIANT | 0.52% | AAOIFI0.9% Usmani3.5% Dow Jones Islamic1.3% S&P Shariah1.5% MSCI Islamic3.5% MSCI Islamic M-Series1.5% FTSE Shariah0.0% |
| PCRX Pacira Biosciences, Inc. | NON_COMPLIANT | 0.51% | AAOIFI39.2% Usmani33.1% Dow Jones Islamic41.2% S&P Shariah37.5% MSCI Islamic33.1% MSCI Islamic M-Series37.5% FTSE Shariah29.2% |
| Azenta, Inc. | UNSCREENED | 0.50% | no in-house ratios for this holding |
| AORT Artivion, Inc. | NON_COMPLIANT | 0.50% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| QDEL QuidelOrtho Corp. | NON_COMPLIANT | 0.47% | AAOIFI321.0% Usmani53.8% Dow Jones Islamic159.8% S&P Shariah123.4% MSCI Islamic53.8% MSCI Islamic M-Series123.4% FTSE Shariah50.6% |
| SDGR Schrodinger, Inc. | NON_COMPLIANT | 0.45% | AAOIFI6.2% Usmani16.9% Dow Jones Islamic7.6% S&P Shariah6.9% MSCI Islamic16.9% MSCI Islamic M-Series6.9% FTSE Shariah0.0% |
| Xencor, Inc. | UNSCREENED | 0.45% | no in-house ratios for this holding |
| CERT Certara, Inc. | NON_COMPLIANT | 0.37% | AAOIFI21.1% Usmani21.6% Dow Jones Islamic19.6% S&P Shariah16.3% MSCI Islamic21.6% MSCI Islamic M-Series16.3% FTSE Shariah20.8% |
| Amphastar Pharmaceuticals, Inc. | UNSCREENED | 0.36% | no in-house ratios for this holding |
| PAHC Phibro Animal Health Corp. | NON_COMPLIANT | 0.34% | AAOIFI43.6% Usmani45.1% Dow Jones Islamic51.7% S&P Shariah64.2% MSCI Islamic45.1% MSCI Islamic M-Series64.2% FTSE Shariah41.3% |
| HSTM HealthStream, Inc. | COMPLIANT | 0.32% | AAOIFI1.6% Usmani2.6% Dow Jones Islamic1.6% S&P Shariah1.7% MSCI Islamic2.6% MSCI Islamic M-Series1.7% FTSE Shariah0.0% |
| Cytek Biosciences, Inc. | UNSCREENED | 0.25% | no in-house ratios for this holding |
| EMBC Embecta Corp. | NON_COMPLIANT | 0.11% | AAOIFI467.7% Usmani118.7% Dow Jones Islamic228.0% S&P Shariah214.9% MSCI Islamic116.2% MSCI Islamic M-Series214.9% FTSE Shariah115.0% |
| Invesco Government & Agency Portfolio | UNSCREENED | 0.04% | no in-house ratios for this holding |
| OABI OmniAb, Inc. | NON_COMPLIANT | 0.00% | AAOIFI3.0% Usmani6.5% Dow Jones Islamic5.9% S&P Shariah4.7% MSCI Islamic6.5% MSCI Islamic M-Series4.7% FTSE Shariah0.0% |
| OABI OmniAb, Inc. | NON_COMPLIANT | 0.00% | AAOIFI3.0% Usmani6.5% Dow Jones Islamic5.9% S&P Shariah4.7% MSCI Islamic6.5% MSCI Islamic M-Series4.7% FTSE Shariah0.0% |
The published standards disagree about this fund by 18 points of portfolio weight — 34.8% of it passes AAOIFI, 16.7% passes MSCI Islamic. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 34.8% ratios fail on 31.8% 63.1% not rated under AAOIFI
ratios pass on 24.8% ratios fail on 41.2% 63.6% not rated under Usmani
ratios pass on 29.5% ratios fail on 35.4% 64.9% not rated under Dow Jones Islamic
ratios pass on 30.5% ratios fail on 34.3% 64.9% not rated under S&P Shariah
ratios pass on 16.7% ratios fail on 49.5% 63.5% not rated under MSCI Islamic
ratios pass on 30.5% ratios fail on 34.3% 64.9% not rated under MSCI Islamic M-Series
ratios pass on 23.7% ratios fail on 42.4% 63.6% not rated under FTSE Shariah
61 of 81 listed holdings carry our own per-methodology verdicts (85% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 52 (71% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
| Non-compliant holding | Weight |
|---|---|
| MOH Molina Healthcare, Inc. | 4.77% |
| KRYS Krystal Biotech, Inc. | 4.25% |
| PTCT PTC Therapeutics, Inc. | 3.16% |
| PTGX Protagonist Therapeutics, Inc. | 3.12% |
| TFX Teleflex Inc. | 3.03% |
| OGN Organon & Co. | 1.85% |
| ICUI ICU Medical, Inc. | 1.78% |
| ITGR Integer Holdings Corp. | 1.67% |
| PRVA Privia Health Group, Inc. | 1.33% |
| TMDX TransMedics Group, Inc. | 1.22% |
Methodology breakdown computing — it will appear here on its own.
Trade setup
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Why this signal?
The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.
Invesco S&P SmallCap Health Care ETF (PSCH) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
🕌 In-house Compliance Research
Computing the full ratio and business-activity breakdown for PSCH — this runs off the critical path so the page paints first. It will appear here on its own.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 61.50 | NEUTRAL |
| Stochastic %K (14) | 97.67 | SELL |
| CCI (20) | 161.60 | SELL |
| Williams %R (14) | -2.33 | SELL |
| MACD (12,26,9) | 0.34 | BUY |
| ROC (10) | 5.43 | BUY |
| Momentum (10) | 2.82 | BUY |
| EMA (10) | 53.63 | BUY |
| SMA (10) | 53.39 | BUY |
| EMA (20) | 53.22 | BUY |
| SMA (20) | 52.63 | BUY |
| EMA (30) | 53.16 | BUY |
| SMA (30) | 52.79 | BUY |
| EMA (50) | 53.05 | BUY |
| SMA (50) | 53.52 | BUY |
| EMA (100) | 51.95 | BUY |
| SMA (100) | 52.86 | BUY |
| EMA (200) | 48.84 | BUY |
| SMA (200) | 48.14 | BUY |
About Invesco S&P SmallCap Health Care ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices, LLC compiles, maintains and calculates the index, which is designed to measure the performance of securities of small-capitalization U.S. companies in the health care sector, as defined by the Global Industry Classification Standard.
Background via Yahoo Finance — informational, not part of the verdict.
Average — needs more confirmation before sizing up
SMC — Top Down
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BULLISH | 41 |
| 🕐 1H | NEUTRAL | 30 |
| ⏱ 15-Min | BULLISH | 120 |
| ⏲ 5-Min | BULLISH | 234 |
Momentum & Volume
Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.
Peer Movement
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
Before you act on this
The questions worth asking about any verdict on this page, answered plainly.
Is a fund screened on its name?
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
What does unrated weight mean?
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
Does the issuer's board make it compliant?
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
How often is this re-screened?
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Compare with
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Insider Activity (90d)
Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.
NO DATA 0 buys · 0 sells
COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-10-20 · Asset managers net 901377 (-14458)
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.